CL2009000799A1 - Composicion de alimento materno que comprende una fuente de lipidos donde los lipidos incluyen al menos un acido graso poliinsaturado de cadena larga seleccionado de: fosfolipidos, fosfatidilcolina, fosfatidiletanolamina, n-acilfosfatidiletanolamina, fosfatidilinositol, fosfatidilserina y/o sus liso derivados; usos. - Google Patents

Composicion de alimento materno que comprende una fuente de lipidos donde los lipidos incluyen al menos un acido graso poliinsaturado de cadena larga seleccionado de: fosfolipidos, fosfatidilcolina, fosfatidiletanolamina, n-acilfosfatidiletanolamina, fosfatidilinositol, fosfatidilserina y/o sus liso derivados; usos.

Info

Publication number
CL2009000799A1
CL2009000799A1 CL2009000799A CL2009000799A CL2009000799A1 CL 2009000799 A1 CL2009000799 A1 CL 2009000799A1 CL 2009000799 A CL2009000799 A CL 2009000799A CL 2009000799 A CL2009000799 A CL 2009000799A CL 2009000799 A1 CL2009000799 A1 CL 2009000799A1
Authority
CL
Chile
Prior art keywords
polyunsaturated fatty
food composition
acylphosphatidylethanolamine
phosphatidylserine
phosphatidylethanolamine
Prior art date
Application number
CL2009000799A
Other languages
English (en)
Inventor
Jean-Baptiste Bezelgues
Frederic Destaillats
Fabiola Dionisi
Cristina Cruz-Hernandez
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2009000799A1 publication Critical patent/CL2009000799A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Composición de alimento materno que comprende una fuente de lípidos que incluye al menos ácidos grasos poliinsaturados de cadena larga y uso de la composición porque sirve para la preparación de un producto a ser consumido por la madre durante el período de embarazo y/o de lactancia, para promover el desarrollo cerebral del neonato.
CL2009000799A 2008-04-01 2009-04-01 Composicion de alimento materno que comprende una fuente de lipidos donde los lipidos incluyen al menos un acido graso poliinsaturado de cadena larga seleccionado de: fosfolipidos, fosfatidilcolina, fosfatidiletanolamina, n-acilfosfatidiletanolamina, fosfatidilinositol, fosfatidilserina y/o sus liso derivados; usos. CL2009000799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08153889A EP2110027A1 (en) 2008-04-01 2008-04-01 Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation

Publications (1)

Publication Number Publication Date
CL2009000799A1 true CL2009000799A1 (es) 2010-04-09

Family

ID=39671366

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000799A CL2009000799A1 (es) 2008-04-01 2009-04-01 Composicion de alimento materno que comprende una fuente de lipidos donde los lipidos incluyen al menos un acido graso poliinsaturado de cadena larga seleccionado de: fosfolipidos, fosfatidilcolina, fosfatidiletanolamina, n-acilfosfatidiletanolamina, fosfatidilinositol, fosfatidilserina y/o sus liso derivados; usos.

Country Status (7)

Country Link
US (1) US20110028434A1 (es)
EP (2) EP2110027A1 (es)
JP (1) JP2011516054A (es)
CN (1) CN102046028A (es)
CL (1) CL2009000799A1 (es)
TW (1) TW200946033A (es)
WO (1) WO2009121839A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
DK2493296T3 (en) 2009-10-30 2019-04-15 Retrotope Inc REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES
NZ599618A (en) 2009-10-30 2014-08-29 Tharos Ltd Solvent-free process for obtaining phospholipids and neutral enriched krill oils
WO2011091160A1 (en) * 2010-01-20 2011-07-28 Henry Wu Custom-formulated phospholipid microbubbles and methods and uses thereof
WO2012087113A1 (en) 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
WO2012148929A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Disorders implicating pufa oxidation
KR102020579B1 (ko) 2011-04-26 2019-09-10 레트로토프 인코포레이티드 에너지 프로세싱 손상 장애 및 미토콘드리아 결함
US10058522B2 (en) * 2011-04-26 2018-08-28 Retrotope, Inc. Oxidative retinal diseases
US10154983B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
WO2012166936A1 (en) * 2011-05-31 2012-12-06 Cargill, Incorporated Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids
PT2734049T (pt) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc Composições e métodos probióticos
IL313986B1 (en) 2012-02-17 2026-05-01 Alcresta Inc Methods, compositions and devices for supplying dietary fatty acid needs
MX363899B (es) 2012-06-18 2019-04-05 Heinz Co Brands H J Llc Trastornos relacionados con gluten.
US20140073598A1 (en) * 2012-09-11 2014-03-13 Jaymac Pharmaceuticals Llc Multiple folate formulation and use thereof
EP2708146A1 (en) * 2012-09-17 2014-03-19 Abbott Laboratories, Inc. Nutritional composition for pregnant women with a beneficial glucose and insulin profile
US20150305363A1 (en) * 2012-12-05 2015-10-29 Cargill, Incorporated Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids and uses thereof
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
WO2015069097A1 (en) 2013-11-08 2015-05-14 N.V. Nutricia Efficacy of dietary dha-phospholipid for brain dha and dpa accretion in neonates
EP3177151B1 (en) * 2014-08-08 2020-04-22 Société des Produits Nestlé S.A. Vitamin b2 and myo-inositol for treating and preventing gestational diabetes
EP3200622A1 (en) * 2014-09-30 2017-08-09 Nestec S.A. Nutritional composition for use to treat or prevent pregnancy related conditions
CN104366606A (zh) * 2014-11-28 2015-02-25 于华华 妇产科保健鲫鱼汤及制备方法
CN104366607A (zh) * 2014-11-28 2015-02-25 于华华 具有催奶功效的鲇鱼汤及制备方法
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
WO2017091279A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
CN108471796A (zh) * 2015-12-14 2018-08-31 雀巢产品技术援助有限公司 用于促进脑的髓鞘形成的营养组合物和婴儿配方食品
EP4205560A1 (en) * 2015-12-14 2023-07-05 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas to promote myelination in the brain
US11986445B2 (en) 2015-12-14 2024-05-21 Societe Des Produits Nestle S.A. Nutritional composition and infant formula for promoting myelination of the brain
AU2016374163A1 (en) * 2015-12-14 2018-04-26 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
SG11201803027PA (en) * 2016-03-30 2018-05-30 Nestec Sa Compositions comprising phospholipid and their use
WO2017167419A1 (en) * 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising minerals and their use
SG11201803026RA (en) * 2016-03-30 2018-05-30 Nestec Sa Compositions comprising choline and their use
MX2018008520A (es) * 2016-03-30 2018-08-16 Nestec Sa Composiciones que comprenden acidos grasos y su uso.
CN107752045A (zh) * 2016-08-23 2018-03-06 安琪酵母股份有限公司 一种含蛋白质的组合物、食品及其制备方法和应用
US12426615B2 (en) 2019-02-21 2025-09-30 Ingenuity Foods, Inc. Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
AU2021213078A1 (en) * 2020-01-30 2022-09-08 Silicycle Inc. Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids
EP4107163A4 (en) 2020-02-21 2024-06-19 Retrotope, Inc. PROCESSES FOR ISOTOPIC MODIFICATION OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES
CN117378012A (zh) * 2021-02-01 2024-01-09 雀巢产品有限公司 用于确定个性化dha补充的方法
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS
US11491130B2 (en) 2021-02-05 2022-11-08 Retrotope, Inc. Methods of treating amyotrophic lateral sclerosis
WO2026162785A1 (en) * 2025-01-31 2026-08-06 Itf Research Pharma, S.L.U. Probiotic composition and use thereof for improving woman fertility

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
DK0661049T3 (da) * 1993-12-31 2000-02-14 Univ Limburg Anvendelse af essentielle fedtsyresammensætninger
CA2251265A1 (en) * 1998-10-21 2000-04-21 Universite De Sherbrooke Process for lipid extraction of aquatic animal tissues producing a dehydrated residue
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
EP1429620A1 (en) * 2001-08-31 2004-06-23 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
KR20060030860A (ko) * 2003-06-24 2006-04-11 유니버시티 오브 캔사스 메디컬 센터 유아 조제유
WO2005061684A1 (ja) * 2003-12-22 2005-07-07 Wakunaga Pharmaceutical Co., Ltd. 油脂組成物
DE10361667A1 (de) * 2003-12-30 2005-07-28 Omega For Life Gmbh Neuartige Fettpulver
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
US20050260302A1 (en) * 2004-05-19 2005-11-24 The Procter & Gamble Company Nutritionally balanced traditional snack foods having a low glycemic response
BRPI0708701A2 (pt) * 2006-03-10 2011-06-07 Nutricia Nv uso de um sacarìdeo não digerìvel solúvel em água
EP1886680A1 (en) * 2006-05-23 2008-02-13 Nestec S.A. Maternal supplement

Also Published As

Publication number Publication date
EP2262382A1 (en) 2010-12-22
US20110028434A1 (en) 2011-02-03
JP2011516054A (ja) 2011-05-26
EP2110027A1 (en) 2009-10-21
CN102046028A (zh) 2011-05-04
WO2009121839A1 (en) 2009-10-08
TW200946033A (en) 2009-11-16

Similar Documents

Publication Publication Date Title
CO6351713A2 (es) Composición nutricional para promover desarrollo y crecimiento sanos
Stables et al. Old and new generation lipid mediators in acute inflammation and resolution
AR101192A1 (es) Composición nutricional que contiene mezclas de aceites y método de promoción de la digestión de grasas y lípidos
PE20140496A1 (es) Proceso para el aislamiento de un fosfolipido
CL2019003105A1 (es) Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560)
NZ709083A (en) Eicosapentaenoic acid (epa) formulations
RU2017139767A (ru) Концентрированные терапевтические фосфолипидные композиции
MX2018003636A (es) Composicion de uridina y citidina para su uso en la prevencion o tratamiento de neurotrauma.
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
AR076959A1 (es) Composicon nutricional para el soporte del desarrollo y la funcion cerebral de los ninos
AR073889A1 (es) Agente de batido.
RU2010129984A (ru) Композиции питательного порошка и детской питательной смеси (варианты)
AR058751A1 (es) Composiciones de alimento para bebes para prevenir la obesidad
RU2010119925A (ru) Способы поддержания или увеличения роста или когнитивного развития
AR005556A1 (es) Formula enteral, un suplemento nutricional que contiene una composicion de trigliceridos, trigliceridos, y un procedimiento para preparar esteres de acidos grasos a partir de una mezcla de lipidos
MX2016003619A (es) Composicion de grasa comestible.
MX2016001063A (es) Composicion nutricional para mejorar el desarrollo del cerebro.
AR093315A1 (es) Producto de confiteria congelado
BRPI0804825A2 (pt) composição de barreira contra umidade comestìvel e método para reduzir a migração de umidade entre alimentos
NZ630210A (en) Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
RU2017129161A (ru) Композиции липидов
AR105144A1 (es) Composiciones nutricionales y métodos para promover el desarrollo cognitivo
BR112015020671A2 (pt) método de aumentar a biodisponibilidade da dha e outros nutrientes solúveis em lipídeos
MX2012010487A (es) Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
AR105237A1 (es) Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico